“Antisense Therapeutics announced todaythat the US Food and Drug Administration (FDA) has granted an Orphan Drug Designation to the ATL1102 for treatment of Duchenne muscular dystrophy. ATL1102 is an antisense drug aimed at reducing muscle inflammation. PPMD is excited for this news and we are happy to see progress.”
Most are angry that the sp hasn’t gone up.. I for one am not angry but disappointed. However it’s another box ticked. We wait..$$$$$
ANP Price at posting:
12.5¢ Sentiment: Buy Disclosure: Held
